94 related articles for article (PubMed ID: 3372163)
1. Increased ocular blood flow and 125I-albumin permeation in galactose-fed rats: inhibition by sorbinil.
Tilton RG; Chang K; Weigel C; Eades D; Sherman WR; Kilo C; Williamson JR
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):861-8. PubMed ID: 3372163
[TBL] [Abstract][Full Text] [Related]
2. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
[TBL] [Abstract][Full Text] [Related]
3. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
[TBL] [Abstract][Full Text] [Related]
5. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
Robison WG; Laver NM; Jacot JL; Glover JP
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
[TBL] [Abstract][Full Text] [Related]
6. Prevention and reversal of galactose cataract in rats with topical Sorbinil.
Hu TS; Merola LO; Kuwabara T; Kinoshita JH
Invest Ophthalmol Vis Sci; 1984 May; 25(5):603-5. PubMed ID: 6715136
[TBL] [Abstract][Full Text] [Related]
7. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
8. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.
Pugliese G; Tilton RG; Speedy A; Santarelli E; Eades DM; Province MA; Kilo C; Sherman WR; Williamson JR
Diabetes; 1990 Mar; 39(3):312-22. PubMed ID: 2307293
[TBL] [Abstract][Full Text] [Related]
9. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
Datiles MB; Kador PF; Kashima K; Kinoshita JH; Sinha A
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
[TBL] [Abstract][Full Text] [Related]
10. Galactose ingestion increases vascular permeability and collagen solubility in normal male rats.
Chang K; Tomlinson M; Jeffrey JR; Tilton RG; Sherman WR; Ackermann KE; Berger RA; Cicero TJ; Kilo C; Williamson JR
J Clin Invest; 1987 Feb; 79(2):367-73. PubMed ID: 3100575
[TBL] [Abstract][Full Text] [Related]
11. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
Bank N; Coco M; Aynedjian HS
Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
[TBL] [Abstract][Full Text] [Related]
12. Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil.
Sutera SP; Chang K; Marvel J; Williamson JR
Am J Physiol; 1992 Sep; 263(3 Pt 2):H945-50. PubMed ID: 1415621
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
Sato S; Mori K; Wyman M; Kador PF
Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
[TBL] [Abstract][Full Text] [Related]
14. Effects of hypothyroidism on vascular 125I-albumin permeation and blood flow in rats.
Tilton RG; Pugliese G; Chang K; Speedy A; Province MA; Kilo C; Williamson JR
Metabolism; 1989 May; 38(5):471-8. PubMed ID: 2725286
[TBL] [Abstract][Full Text] [Related]
15. Iris vasculopathy in galactose-fed rats.
Caspers-Velu LE; Wadhwani KC; Rapoport SI; Kador PF
Exp Eye Res; 1999 Feb; 68(2):211-21. PubMed ID: 10068486
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
[TBL] [Abstract][Full Text] [Related]
17. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
Lightman S; Rechthand E; Terubayashi H; Palestine A; Rapoport S; Kador P
Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
[TBL] [Abstract][Full Text] [Related]
18. Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.
Frank RN; Keirn RJ; Kennedy A; Frank KW
Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1519-24. PubMed ID: 6642931
[TBL] [Abstract][Full Text] [Related]
19. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration.
Williamson JR; Chang K; Tilton RG; Prater C; Jeffrey JR; Weigel C; Sherman WR; Eades DM; Kilo C
Diabetes; 1987 Jul; 36(7):813-21. PubMed ID: 3108058
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
